7 hours ago
📉 Trade AVAX/USDT at $26.0803!
🚀 #Avalanche is dipping, presenting a great opportunity to buy low.
Start trading now on Koinpark! 💹
Trade Now: https://www.koinpark.com/t...
#cryptotrading #AVAX #USDT #globalcryptoexchange #crytocurrency #cryptoinvestors #koinpark
🚀 #Avalanche is dipping, presenting a great opportunity to buy low.
Start trading now on Koinpark! 💹
Trade Now: https://www.koinpark.com/t...
#cryptotrading #AVAX #USDT #globalcryptoexchange #crytocurrency #cryptoinvestors #koinpark
1 day ago
#Avalanche Foundation repurchased $60M in $AVAX tokens, boosting bullish sentiment
AVAX is testing key support/resistance near $30, with 7% surge recently
Potential inverted head & shoulders pattern signals upward movement
Upcoming token unlock could create short-term selling pressure, affecting prices
https://coinpedia.org/news...
AVAX is testing key support/resistance near $30, with 7% surge recently
Potential inverted head & shoulders pattern signals upward movement
Upcoming token unlock could create short-term selling pressure, affecting prices
https://coinpedia.org/news...
Avalanche Foundation Buys Back $60 Million in AVAX Tokens: Bull Rally Incoming?
AVAX surges 7% in October, testing key resistance at $30. Buyback plans and token unlock event could shape Avalanche's near-term outlook
https://coinpedia.org/news/avalanche-avax-price-poised-for-40-surge-ahead-of-token-buyback-from-terra/
14 days ago
🚀 Can $AVAX Break Through Resistance? 🚀
As it trades at $28.37, investor interest surges with a 57% trading volume increase!
Will it reach the $70 target, or will resistance hold? 🔍💰
#Avalanche #cryptonews #crypto
https://cryptochampz.blogs...
As it trades at $28.37, investor interest surges with a 57% trading volume increase!
Will it reach the $70 target, or will resistance hold? 🔍💰
#Avalanche #cryptonews #crypto
https://cryptochampz.blogs...
Can AVAX break through the $28.66 resistance?
https://cryptochampz.blogspot.com/2024/09/can-avax-break-through-2866-resistance.html
18 days ago
🚀 #Avalanche is on FIRE!
With a recent $AVAX price surge and exciting upgrades, is AVAX the next big thing in #crypto ?
Analysts predict it could hit $30.15 this month! 🌟 #investing #AVAXPricePrediction
https://cryptoalerts.hashn...
With a recent $AVAX price surge and exciting upgrades, is AVAX the next big thing in #crypto ?
Analysts predict it could hit $30.15 this month! 🌟 #investing #AVAXPricePrediction
https://cryptoalerts.hashn...
25 days ago
Analyst Captain Faibik predicts #Avalanche could surge 183% to $45 if it holds above $26 support
$AVAX breakout from a 6-month correction signals a potential rally
Market share has grown to 0.92%, showing rising demand
https://coinpedia.org/news...
$AVAX breakout from a 6-month correction signals a potential rally
Market share has grown to 0.92%, showing rising demand
https://coinpedia.org/news...
Avalanche (AVAX) Price Could Soar 183% to $45, Predicts Analyst - Here's Why
Avalanche (AVAX) is catching the eye of crypto traders as well-known analyst Captain Faibik predicts a significant price surge. Spotting a bullish
https://coinpedia.org/news/top-trader-predict-avalanche-avax-set-for-a-big-breakout-can-it-reach-45-soon/
3 months ago
August will see $1.5 billion in #crypto tokens unlocked
#ripple leads with a $609M $XRP release on August 1
Major releases #Avalanche $268M $AVAX #Wormhole $180.5M
$Sui, dYdX, ZetaChain, ImmutableX, Aptos, The Sandbox, Starknet, Arbitrum
https://coinpedia.org/news...
#ripple leads with a $609M $XRP release on August 1
Major releases #Avalanche $268M $AVAX #Wormhole $180.5M
$Sui, dYdX, ZetaChain, ImmutableX, Aptos, The Sandbox, Starknet, Arbitrum
https://coinpedia.org/news...
XRP News Today: Ripple-Led $1.5 Billion Token Flood to Hit Market in August
August is set to be a significant month for the cryptocurrency market, with nearly $1.5 billion worth of tokens being unlocked. Leading the charge is
https://coinpedia.org/news/xrp-news-today-ripple-leads-1-5-billion-crypto-token-unlock-in-august/
4 months ago
Vaccines Market Worth $90.52 Billion by 2032
Washington, DC, United States: Vantage Market Research has recently added a new report on Vaccines Market Report History and Forecast 2024-2032, Breakdown Data by Size, Share, Trends, Manufacturers, Challenges, Key Regions, Types and Application.
According to Vantage Market Research, the Global Vaccines Market is estimated to be valued at USD 90.52 Billion by 2030 at an exponential growth rate of 9.5% in the next seven years.
The global Vaccines Market is poised for unprecedented growth, with projections indicating substantial expansion by 2032. A comprehensive research report, "Global Vaccines Market Research Report 2024," delves into the factors driving this surge and offers invaluable insights into this vital industry.
Key Players Mentioned in the Global Vaccines Market Research Report: GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Pfizer Inc. (US), Sanofi SA (France), CSL Limited (Australia), Emergent BioSolutions Inc. (US), Johnson & Johnson (US), AstraZeneca plc (UK), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic A/S (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo Company, Limited (Japan), Panacea Biotec, Ltd. (India), Biological E Limited (India), Bharat Biotech Ltd. (India), Novavax Inc. (US), FSUE NPO Microgen (Russia), Sinovac Biotech, Ltd. (China), Incepta Vaccine Limited (Bangladesh), Valneva SE (France), VBI Vaccines (US), PT Bio Farma (Persero) (Indonesia), Inovio Ph
Washington, DC, United States: Vantage Market Research has recently added a new report on Vaccines Market Report History and Forecast 2024-2032, Breakdown Data by Size, Share, Trends, Manufacturers, Challenges, Key Regions, Types and Application.
According to Vantage Market Research, the Global Vaccines Market is estimated to be valued at USD 90.52 Billion by 2030 at an exponential growth rate of 9.5% in the next seven years.
The global Vaccines Market is poised for unprecedented growth, with projections indicating substantial expansion by 2032. A comprehensive research report, "Global Vaccines Market Research Report 2024," delves into the factors driving this surge and offers invaluable insights into this vital industry.
Key Players Mentioned in the Global Vaccines Market Research Report: GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Pfizer Inc. (US), Sanofi SA (France), CSL Limited (Australia), Emergent BioSolutions Inc. (US), Johnson & Johnson (US), AstraZeneca plc (UK), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic A/S (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo Company, Limited (Japan), Panacea Biotec, Ltd. (India), Biological E Limited (India), Bharat Biotech Ltd. (India), Novavax Inc. (US), FSUE NPO Microgen (Russia), Sinovac Biotech, Ltd. (China), Incepta Vaccine Limited (Bangladesh), Valneva SE (France), VBI Vaccines (US), PT Bio Farma (Persero) (Indonesia), Inovio Ph
4 months ago
#bitcoin dropped below $65K amid ETF outflows and Fed's hawkish stance.
CryptosRUs predicts 100% surge in 15 days due to strong fundamentals.
Altcoins like $ETH, $AVAX, and $SOL may also rise. Patience advised.
https://coinpedia.org/news...
CryptosRUs predicts 100% surge in 15 days due to strong fundamentals.
Altcoins like $ETH, $AVAX, and $SOL may also rise. Patience advised.
https://coinpedia.org/news...
Why Bitcoin Price Could Surge 100% in 15 Days : Decoding The Truth
Bitcoin price drops below $65,000 amid ETF outflows and Fed's stance, but CryptosRUs' George predicts a potential doubling in value
https://coinpedia.org/news/why-bitcoin-price-could-surge-100-in-15-days-decoding-the-truth/
5 months ago
Representative currencies of each major sector:
💹1. MEME sector DOGE, SHIB, PEPE, FLOKI, BONK
💹2. AI sector AGIX, WLD, FET, AI, NMR
💹3. Public chain sector ETH, SOL, MATIC, FTM, ADA, AVAX, DOT, ATOM
💹4. LAYER2 sector OP, ARB, METIS, IMX, MANTA, EGLD, MNT
💹5. 2024 halving sector BCH, BSV, ZEC, ZEN, BTG
💹6. GAMEFI sector SAND, MANA, GALA, ENJ, RON, PIXEL, ACE, ILV, MAGIC, YGG
💹7. Oracle sector TRB, LINK, API3, TRB, BAND
💹8. Payment concept sector MOB, ACH, XLM, CELO
💹9. Inscription sector ORDI, SATS, RATS
💹10. Storage sector AR, FIL, STORJ, BLZ
💹11. DEFI sector AAVE, COMP, RDNT, CRV, MKR, AVAX, DYDX
💹12. NFT sector BLUR, DYDX, LOOKS, DEGO
💹13. Modular sector TIA, MANTA, DYM, ALT,
💹14. Sports sector CHZ, SANTOS, POR, CITY
💹1. MEME sector DOGE, SHIB, PEPE, FLOKI, BONK
💹2. AI sector AGIX, WLD, FET, AI, NMR
💹3. Public chain sector ETH, SOL, MATIC, FTM, ADA, AVAX, DOT, ATOM
💹4. LAYER2 sector OP, ARB, METIS, IMX, MANTA, EGLD, MNT
💹5. 2024 halving sector BCH, BSV, ZEC, ZEN, BTG
💹6. GAMEFI sector SAND, MANA, GALA, ENJ, RON, PIXEL, ACE, ILV, MAGIC, YGG
💹7. Oracle sector TRB, LINK, API3, TRB, BAND
💹8. Payment concept sector MOB, ACH, XLM, CELO
💹9. Inscription sector ORDI, SATS, RATS
💹10. Storage sector AR, FIL, STORJ, BLZ
💹11. DEFI sector AAVE, COMP, RDNT, CRV, MKR, AVAX, DYDX
💹12. NFT sector BLUR, DYDX, LOOKS, DEGO
💹13. Modular sector TIA, MANTA, DYM, ALT,
💹14. Sports sector CHZ, SANTOS, POR, CITY
5 months ago
AVAX Price Stalled: Moon Mission on Hold?
AVAX faces a triple top threat, with a sideways trend dampening spirits.
Key Points:
AVAX price faces a potential triple top threat, indicating a bearish reversal if the price breaks below $30.
The current sideways trend suggests a lack of momentum and indecision among buyers and sellers.
A bullish surge above $40 could reignite the uptrend and push AVAX towards $68.
So, will AVAX price reach $100 this year? What will the upcoming week hold for AVAX? Read more for the full analysis!https://coinpedia.org/pric...
AVAX faces a triple top threat, with a sideways trend dampening spirits.
Key Points:
AVAX price faces a potential triple top threat, indicating a bearish reversal if the price breaks below $30.
The current sideways trend suggests a lack of momentum and indecision among buyers and sellers.
A bullish surge above $40 could reignite the uptrend and push AVAX towards $68.
So, will AVAX price reach $100 this year? What will the upcoming week hold for AVAX? Read more for the full analysis!https://coinpedia.org/pric...
5 months ago
Covid-19 Vaccine Market Size, Share, Growth Forecast 2023-2032
The Covid-19 Vaccine Market Industry Report 2032 is an in depth study analyzing the current state of the Covid-19 Vaccine Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Covid-19 Vaccine Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Covid-19 Vaccine Market also discusses the opportunity areas for investors.
Download Sample Report Copy From Here: https://www.acumenresearch...
The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Market Segmentation:
Market By Product Type
Covishield
Covaxin
BNT162b2
mRNA-1273
JNJ-78436735
Sputnik V
Covi-Vac
Other
Market By Application
Adults
Childers
Market By End Use
Hospital
Clinic
Table Of Contents: https://www.acumenresearch...
Market Players as below:
The players profiled in the report are Pfizer, Inc., ModernaTX, Inc., Janssen Pharmaceuticals Company, AstraZeneca, Novavax, Bharat Biotech, Gamaleya Research Institute, Chumakov, Vector State Research Center, and CNBG Beijing.
To Purchase this Premium Report@ https://www.acumenresearch...
Contact +918983225533
The Covid-19 Vaccine Market Industry Report 2032 is an in depth study analyzing the current state of the Covid-19 Vaccine Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Covid-19 Vaccine Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Covid-19 Vaccine Market also discusses the opportunity areas for investors.
Download Sample Report Copy From Here: https://www.acumenresearch...
The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Market Segmentation:
Market By Product Type
Covishield
Covaxin
BNT162b2
mRNA-1273
JNJ-78436735
Sputnik V
Covi-Vac
Other
Market By Application
Adults
Childers
Market By End Use
Hospital
Clinic
Table Of Contents: https://www.acumenresearch...
Market Players as below:
The players profiled in the report are Pfizer, Inc., ModernaTX, Inc., Janssen Pharmaceuticals Company, AstraZeneca, Novavax, Bharat Biotech, Gamaleya Research Institute, Chumakov, Vector State Research Center, and CNBG Beijing.
To Purchase this Premium Report@ https://www.acumenresearch...
Contact +918983225533
6 months ago
Peanut Allergy Treatment Market Size, Share, Growth Trends and Forecast 2023 - 2032
The Peanut Allergy Treatment Market Industry Report 2032 is an in depth study analyzing the current state of the Peanut Allergy Treatment Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Peanut Allergy Treatment Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Peanut Allergy Treatment Market also discusses the opportunity areas for investors.
Download Sample Report Copy From Here: https://www.acumenresearch...
The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Market Segmentation:
The global Peanut Allergy Treatment Market segmentation is based on drug class, route of administration, distribution channel, and geography.
Peanut Allergy Treatment Market By Drug Class
Antihistamines
Immunotherapies
Epinephrine
Others
Peanut Allergy Treatment Market By Route Of Administration
Injectable
Oral
Others
Peanut Allergy Treatment Market By Distribution Channel
Retail Pharmacy
Hospital Pharmacy
Others
Table Of Contents: https://www.acumenresearch...
Market Players as below:
Some of the top peanut allergy treatment market companies offered in the professional report include Aimmune Therapeutics Inc., Sanofi, Aravax Pty Ltd, Regeneron Pharmaceuticals Inc., Alladapt Immunotherapeutics, Inc., DBV Technologies, Prota Therapeutics, Vedanta Biosciences, Inc., and Teva Pharmaceuticals Industries Ltd.
Ask Query Here: Richardacumenresearchandconsulting.com or salesacumenresearchandconsulting.com
To Purchase this Premium Report@ https://www.acumenresearch...
The Peanut Allergy Treatment Market Industry Report 2032 is an in depth study analyzing the current state of the Peanut Allergy Treatment Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Peanut Allergy Treatment Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Peanut Allergy Treatment Market also discusses the opportunity areas for investors.
Download Sample Report Copy From Here: https://www.acumenresearch...
The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Market Segmentation:
The global Peanut Allergy Treatment Market segmentation is based on drug class, route of administration, distribution channel, and geography.
Peanut Allergy Treatment Market By Drug Class
Antihistamines
Immunotherapies
Epinephrine
Others
Peanut Allergy Treatment Market By Route Of Administration
Injectable
Oral
Others
Peanut Allergy Treatment Market By Distribution Channel
Retail Pharmacy
Hospital Pharmacy
Others
Table Of Contents: https://www.acumenresearch...
Market Players as below:
Some of the top peanut allergy treatment market companies offered in the professional report include Aimmune Therapeutics Inc., Sanofi, Aravax Pty Ltd, Regeneron Pharmaceuticals Inc., Alladapt Immunotherapeutics, Inc., DBV Technologies, Prota Therapeutics, Vedanta Biosciences, Inc., and Teva Pharmaceuticals Industries Ltd.
Ask Query Here: Richardacumenresearchandconsulting.com or salesacumenresearchandconsulting.com
To Purchase this Premium Report@ https://www.acumenresearch...
6 months ago
Avian Influenza Drug Market size is Projected to Reach USD 32.26 billion by 2028 | Growing at a CAGR of 6.00% from 2024 to 2028
The global Avian Influenza Drug market research report, as published by Market Insight Reports, provides insights into the current global outlook and key regions, examining Major Players, Countries, Product Types, and end industries. It focuses on top players in the global market and categorizes the market based on several parameters.
This Avian Influenza Drug market research report identifies the competitive landscape of industries, offering a comprehensive understanding of international competition. The study outlines the anticipated growth of the global market during forecast period. Compiled with a blend of static and dynamic perspectives, this research report captures the essence of the business’s views.
The avian influenza drug market is expected to gain growth at a potential rate of 6.00% in the forecast period of 2021 to 2028. The emergence of drugs used in the treatment of risk associated with avian influenza viral infection is the factor responsible for the market growth.
Access Full Report: Top Industry Players:
The major players covered in the avian influenza drug market report are GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Allergan, Novartis AG, Baxter, BIOCRYST PHARMACEUTICALS, INC., UNM Pharma Inc., CSL Limited, Emergent BioSolutions Inc., Novavax, Inc., Medigen Biotechnology Corp, BiondVax Pharmaceuticals Ltd., INOVIO Pharmaceuticals, Vaxart, Inc., Johnson & Johnson Services, Inc., SINOVAC,Boehringer Ingelheim International GmbH, Ceva, Zoetis and Qianyuanhao Biological Co., Ltd., among other domestic and global players. Avian influenza drug market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market Segmentation:
The avian influenza drug market is segmented on the basis of strain type, treatment type, route of administration, application, distribution channel and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
On the basis of strain type, the avian influenza drug market can be segmented into H5N1, H5N6, H6N1, H7N4, H7N9, H9N2 and H10N8.
Based on
The global Avian Influenza Drug market research report, as published by Market Insight Reports, provides insights into the current global outlook and key regions, examining Major Players, Countries, Product Types, and end industries. It focuses on top players in the global market and categorizes the market based on several parameters.
This Avian Influenza Drug market research report identifies the competitive landscape of industries, offering a comprehensive understanding of international competition. The study outlines the anticipated growth of the global market during forecast period. Compiled with a blend of static and dynamic perspectives, this research report captures the essence of the business’s views.
The avian influenza drug market is expected to gain growth at a potential rate of 6.00% in the forecast period of 2021 to 2028. The emergence of drugs used in the treatment of risk associated with avian influenza viral infection is the factor responsible for the market growth.
Access Full Report: Top Industry Players:
The major players covered in the avian influenza drug market report are GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Allergan, Novartis AG, Baxter, BIOCRYST PHARMACEUTICALS, INC., UNM Pharma Inc., CSL Limited, Emergent BioSolutions Inc., Novavax, Inc., Medigen Biotechnology Corp, BiondVax Pharmaceuticals Ltd., INOVIO Pharmaceuticals, Vaxart, Inc., Johnson & Johnson Services, Inc., SINOVAC,Boehringer Ingelheim International GmbH, Ceva, Zoetis and Qianyuanhao Biological Co., Ltd., among other domestic and global players. Avian influenza drug market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market Segmentation:
The avian influenza drug market is segmented on the basis of strain type, treatment type, route of administration, application, distribution channel and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
On the basis of strain type, the avian influenza drug market can be segmented into H5N1, H5N6, H6N1, H7N4, H7N9, H9N2 and H10N8.
Based on
December 09, 2023
➖➖➖➖➖➖➖
MARKET ANALYSIS:
Market Cap: $1.64 Trillion
24h Volume: $67.14 Billion
BTC Dominance: 52.6%
ETH Dominance: 17.2%
🔸BK® Health Standard: 6.4 (1 to 10)
🔸BK® Sentiment: 48% (-100% to 100%)
➖➖➖➖➖➖➖
BINANCE ANALYSIS (USDT pairs):
Top Gainers
1. QI: +61%
2. RAY: +38%
3. GFT: +27%
Top Losers
1. OP: -5%
2. RIF: -4%
3. RDNT: -3%
BINANCE FUTURES:
Top Gainers
1. ADAUSDT: +23%
2. AVAXUSDT: +21%
Top Losers
1. OPUSDT: -4%
2. RIFUSDT: -3%
LARGEST VOLUME (24h)
1. BTC/USDT ($25000m)
2. ETH/USDT ($12000m)
DAILY OUTLOOK
QI, RAY, and GFT have emerged as the standout performers in the current market, displaying substantial gains. Particularly noteworthy is the strength exhibited by BTC, underscoring the significance of closely monitoring the weekly candle close. The prevailing market sentiments lean decisively towards a bullish outlook, raising expectations for a potential upward surge in the days ahead.
➖➖➖➖➖➖➖
- Binance Killers®
➖➖➖➖➖➖➖
MARKET ANALYSIS:
Market Cap: $1.64 Trillion
24h Volume: $67.14 Billion
BTC Dominance: 52.6%
ETH Dominance: 17.2%
🔸BK® Health Standard: 6.4 (1 to 10)
🔸BK® Sentiment: 48% (-100% to 100%)
➖➖➖➖➖➖➖
BINANCE ANALYSIS (USDT pairs):
Top Gainers
1. QI: +61%
2. RAY: +38%
3. GFT: +27%
Top Losers
1. OP: -5%
2. RIF: -4%
3. RDNT: -3%
BINANCE FUTURES:
Top Gainers
1. ADAUSDT: +23%
2. AVAXUSDT: +21%
Top Losers
1. OPUSDT: -4%
2. RIFUSDT: -3%
LARGEST VOLUME (24h)
1. BTC/USDT ($25000m)
2. ETH/USDT ($12000m)
DAILY OUTLOOK
QI, RAY, and GFT have emerged as the standout performers in the current market, displaying substantial gains. Particularly noteworthy is the strength exhibited by BTC, underscoring the significance of closely monitoring the weekly candle close. The prevailing market sentiments lean decisively towards a bullish outlook, raising expectations for a potential upward surge in the days ahead.
➖➖➖➖➖➖➖
- Binance Killers®